NCT00327249View on ClinicalTrials.gov

Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

January 31, 2008

Conditions
Multiple Myeloma
Interventions
DRUG

imexon

Trial Locations (2)

72206

Investigational Site 025, Little Rock

77030

Investigational Site 008, Houston

Sponsors
All Listed Sponsors
lead

AmpliMed Corporation

INDUSTRY